Tarlatamab plus durvalumab improves survival in extensive-stage small cell lung cancer

ESMO 2026: Highlights and analysis

Adding nivolumab to perioperative chemo shows no significant benefit in muscle invasive bladder cancer

ESMO 2026: Advances in NMIBC and MIBC

Perioperative apalutamide plus ADT improves event free survival in high risk localised prostate cancer

UV1 vaccine combination shows no significant PFS improvement in BRCA wild type recurrent ovarian cancer

UEG 2026: Improving early detection of colorectal cancer

Safeguarding the right to work for people with advanced breast cancer (ABC) and their caregivers: A global snapshot of legislati

Equitable precision oncology in Africa

Harnessing AI and data to predict, personalise and transform cancer care

Sequencing breast cancer scale-up in LMICs: Using service assessment to shape national priorities in Ethiopia

Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout